arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

HEALTHY CHOICE WELLNESS CORP.

HCWC

$0.25 ▲ +0.05 (+23.76%) at close

4 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

HEALTHY CHOICE WELLNESS CORP. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.1M

Dividend Yield —

Revenue Growth 12.7% ↘

Op. Margin -3.2% ↘

ROIC -13.4% ↘

FCF / Share $0.04 ↗

Trailing P/E —

Price / Book 0.7x

FCF Yield 16.3%

Debt / Equity 1.00

info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$78.21M

↑ +12.7% —

Net Income Profit after all expenses

$-3.94M

↑ +12.7% —

Operating Margin Operating profit as % of sales

-3.2%

↓ -24.0% 22th

FCF / Share Free cash flow per share

$0.04

↑ +111.5% —

Long-Term Debt Long-term obligations

$7.30M

↓ -35.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	12.7% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+218%)	24.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+514%)	—	—
EPS Growth YoY (%)	50.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	55.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	12.7% Fair Fair Year-over-year change in net income	54.6% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	-20.4% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	-3.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-121%)	-2.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-117%)	-18.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-226%)	—
Profit Margin (%) (%)	-5.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-150%)	-6.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-165%)	-17.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-278%)	—
FCF Margin (%) (%)	0.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-4.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-4.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-13.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-68.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-7.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-37.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-53.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-316%)	-189.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-857%)	-110.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-542%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	1.00x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+43%)	4.76x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+581%)	0.35x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-51%)	—
Interest Coverage (x)	-4.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	-52.70x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$4.28M	$9.28M	$1.71M	—
Debt / EBITDA (x)	-9.36x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-56.41x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$4.72	$7.38	$6.04	—
Basic EPS, GAAP (USD)	$-0.24	$-0.48	$-1.08	—
Free Cash Flow per Share (USD)	$0.04	$-0.35	$-0.29	—
Book Value per Share (USD)	$0.37	$0.24	$0.97	—
Tangible Book Value per Share (USD)	$0.04	$-0.54	$0.52	—
Basic Weighted Avg Shares (shares)	16.57M	9.40M	9.23M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$-2.73M	$-2.23M	$-2.63M	—
LT Debt (USD)	$7.30M	$11.34M	$3.11M	—
Total Equity (USD)	$7.31M	$2.38M	$8.99M	$15.51M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$78.21M	$69.37M	$55.69M	—
Depreciation Expense (USD)	$1.70M	$1.58M	—	—
Net Income, GAAP (USD)	$-3.94M	$-4.51M	$-9.93M	—
Operating Cash Flow (USD)	$996.05K	$-3.06M	$-2.53M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 13 quarters

HEALTHY CHOICE WELLNESS CORP.

Analytical Summary

4-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HCWC with peers